Results 91 to 100 of about 53,395 (273)
Through an international survey, we aimed to investigate the current international methods implemented for proton therapy patient selection and to determine whether COVID‐19 has impacted practice. Only one of nine respondents reported changes to patient selection approaches during the height of the pandemic, mainly ceasing use of clinical trial group ...
Lucy Wood+5 more
wiley +1 more source
Donut-Shaped High-Dose Configuration for Proton Beam Radiation Therapy [PDF]
Hans Rutz, Antony Lomax
openalex +1 more source
A novel bio‐based hydrogel was developed using Mallotus philippensis extract, Lucast bean gum, and chitosan for controlled levofloxacin release. The hydrogel exhibited excellent swelling behavior, antimicrobial activity, and pH‐responsive drug release, demonstrating its potential for advanced wound healing and targeted drug delivery applications ...
Sehrish Jabeen+3 more
wiley +1 more source
The potential of proton beam radiation therapy in head and neck cancer [PDF]
Anders Ask+4 more
openalex +1 more source
Mass spectrometry imaging of N‐linked glycans: Fundamentals and recent advances
Abstract With implications in several medical conditions, N‐linked glycosylation is one of the most important posttranslation modifications present in all living organisms. Due to their nontemplate synthesis, glycan structures are extraordinarily complex and require multiple analytical techniques for complete structural elucidation.
Tana V. Palomino, David C. Muddiman
wiley +1 more source
Repeated Proton Beam Therapy for Hepatocellular Carcinoma [PDF]
T. Hashimoto+11 more
openalex +1 more source
Abstract Cyclodepsipeptides (CDPs) represent a huge family of chemically and structurally diverse molecules with a wide ability for molecular interactions. CDPs are cyclic peptide‐related natural products made up of both proteinogenic and nonproteinogenic amino acids linked by amide and ester bonds.
Sophie Liuu+10 more
wiley +1 more source
Proton beam therapy for iris melanoma: a review of 15 cases [PDF]
Paul Rundle, Arun D. Singh, I G Rennie
openalex +1 more source
ABSTRACT Targeted radioligand therapy has emerged as a promising treatment option for eradicating advanced cancer forms. α‐Emitters are considered particularly promising as they can obliterate (micro)‐metastases. The α‐emitter astatine‐211 (211At) has experienced increased interest due to its favorable decay properties.
Marius Müller+5 more
wiley +1 more source